The prognosis of CN-AML depends on the molecular status (e.g., FLT3, NPM1, CEBPA, IDH1/2, DNMT3A, MLL, ERG, MN1 and micro-RNA-181a and 3151); however, not all candidate markers have been detected so far. Here, IDH1 is linked to acute myeloid leukemia.